Patent delisted for Boehringer Ingelheim drug JARDIANCE

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post Patent delisted for Boehringer Ingelheim drug JARDIANCE a…


Patent delisted for Boehringer Ingelheim drug JENTADUETO

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post Patent delisted for Boehringer Ingelheim drug JENTADU…


Biotechblog